Integrated safety analysis of umbralisib, a dual PI3Kδ/CK1ε inhibitor, in relapsed/refractory lymphoid malignancies
umbralisib(一种双重PI3Kδ/CK1ε抑制剂)在复发/难治性淋巴瘤中的综合安全性分析
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2021005132
Davids, Matthew S; O'Connor, Owen A; Jurczak, Wojciech; Samaniego, Felipe; Fenske, Timothy S; Zinzani, Pier Luigi; Patel, Manish R; Ghosh, Nilanjan; Cheson, Bruce D; Derenzini, Enrico; Brander, Danielle M; Reeves, James A; Knopińska-Posłuszny, Wanda; Allan, John N; Phillips, Tycel; Caimi, Paolo F; Lech-Maranda, Ewa; Burke, John M; Agajanian, Richy; Pettengell, Ruth; Leslie, Lori A; Cheah, Chan Y; Fonseca, Gustavo; Essell, James; Chavez, Julio C; Pagel, John M; Sharman, Jeff P; Hsu, Yanzhi; Miskin, Hari P; Sportelli, Peter; Weiss, Michael S; Flinn, Ian W